Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Alan N. Bateson"'
Autor:
Philip M. Hopkins, Fanning Zeng, Alexandra M. Dedman, Carol J. Milligan, Alan N. Bateson, Yahya M Bahnasi, David J. Beech, H M Wright
Publikováno v:
British Journal of Pharmacology. 153:1505-1512
Background and purpose: TRPC5 is a mammalian homologue of the Drosophila Transient Receptor Potential (TRP) channel and has expression and functions in the cardiovascular and nervous systems. It forms a calcium-permeable cation channel that can be ac
Autor:
Alan N. Bateson
Publikováno v:
Sleep Medicine. 7:S3-S9
The benzodiazepine binding site on the GABA A receptor is the target for the majority of hypnotics, including the nonbenzodiazepine ‘Z drugs' (zaleplon, zolpidem, zopiclone and eszopiclone). Concerns still exist over long-term benzodiazepine use, a
A Sphingosine-1–Phosphate-Activated Calcium Channel Controlling Vascular Smooth Muscle Cell Motility
Autor:
Alexandra M. Dedman, Alex Cheong, Damian McHugh, Samir S. Shah, Karen E. Porter, Katsuhiko Muraki, David J. Beech, Alan N. Bateson, Piruthivi Sukumar, Jacqueline Naylor, Jing Li, Fanning Zeng, Philippa K. Flemming, Shang-Zhong Xu, Christopher M. Munsch
Publikováno v:
Circulation Research. 98:1381-1389
In a screen of potential lipid regulators of transient receptor potential (TRP) channels, we identified sphingosine-1–phosphate (S1P) as an activator of TRPC5. We explored the relevance to vascular biology because S1P is a key cardiovascular signal
Autor:
Alexandra M. Dedman, Fanning Zeng, Shang-Zhong Xu, David J. Beech, Jing Li, Philippa K. Flemming, Jacqueline Naylor, Katsuhiko Muraki, Alan N. Bateson, Christopher D. Benham
Publikováno v:
Journal of Biological Chemistry. 281:4977-4982
TRPC calcium channels are emerging as a ubiquitous feature of vertebrate cells, but understanding of them is hampered by limited knowledge of the mechanisms of activation and identity of endogenous regulators. We have revealed that one of the TRPC ch
Autor:
Alan N. Bateson
Publikováno v:
Sleep Medicine. 5:S9-S15
The gamma-aminobutyric acid-A (GABA(A)) receptors is the target for the most widely prescribed sleep medicines. It is a ligand-gated ion channel, activated by the amino acid neurotransmitter GABA, which normally results in hyperpolarization of neuron
Autor:
Chris Peers, Michael L.J. Ashford, Stephen Paul Brazier, Alan N. Bateson, Matthew E. Hartness, Paul J. Kemp
Publikováno v:
Journal of Biological Chemistry. 278:51422-51432
Various cardiorespiratory diseases (e.g. congestive heart failure, emphysema) result in systemic hypoxia and patients consequently demonstrate adaptive cellular responses which predispose them to conditions such as pulmonary hypertension and stroke.
Publikováno v:
Journal of Neurochemistry. 70:2188-2194
His101 of the GABA(A) receptor alpha1 subunit is an important determinant of benzodiazepine recognition and a major site of photolabeling by [3H]flunitrazepam. To investigate further the chemical specificity of the residue in this position, we substi
Publikováno v:
Molecular Biotechnology. 14:25-46
Receptor-ligand interactions have traditionally been evaluated using a number of biochemical techniques including radioligand binding, photoaffinity labeling, crosslinking, and chemical modification. In modern biochemistry, these approaches have larg
Autor:
Sandra E. File, Michelle I. Arnot, Alan N. Bateson, Cathy Fernandes, Elaine E. Irvine, Ian L. Martin
Publikováno v:
Psychopharmacology. 145:251-259
Rationale: Chronic treatment with benzodiazepines results in tolerance to their sedative and anxiolytic effects and there is considerable evidence that different mechanisms underlie the development of tolerance to different behavioural effects. Objec
Autor:
Gregory J.R. Charrois, Chien-Tsai Lai, Glen B. Baker, Alan N. Bateson, Véronique A.-M. I. Tanay
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 357:32-38
There is an increasing body of evidence suggesting that GABA plays an important role in the therapeutic effects of antidepressant/antipanic drugs. Phenelzine and imipramine are efficacious in the treatment of depression and panic disorder and phenelz